Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
SUBSCRIBE FOR FREE
Facebook
Twitter
LinkedIn
Cancerworld Magazine
Cancerworld Magazine
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine > News > Colorectal cancer linked to lifetime of excess weight
  • News

Colorectal cancer linked to lifetime of excess weight

  • 30 March 2022
  • Janet Fricker
Colorectal cancer linked to lifetime of excess weight
Total
0
Shares
0
0
0
0
0

Cumulative lifetime exposure to excess weight accounts for a larger share of Colorectal cancer (CRC) risk than previously appreciated. The German study, published in JAMA Oncology, 17 March, demonstrates the importance of characterizing long-term exposure to weight gain and making weight loss a public health priority.

“The observed associations suggest that having overweight or obesity since a young adult age is a persistent risk factor of CRC throughout the adult life span and that consideration of cumulative exposure to excess weight throughout the life span is essential to disclose its full effects,” write the authors, led by Hermann Brenner, from the German Cancer Research Centre, Heidelberg, Germany.

Excess weight is a well-established risk factor for CRC. According to the World Health Organization (WHO), at least 300 million adults world-wide are obese and 1.4 billion overweight. Most epidemiologic studies have assessed CRC associations with excess weight recorded at a single point of time. “However, exposure to excess weight throughout life is likely to be more relevant for CRC risk, especially considering that one of the suggested underlying mechanisms is the continuous release of growth factors and steroids with an environment of chronic inflammation and insulin resistance,” write the authors.

In the current study, Brenner and colleagues aimed to derive a measure of cumulative life-time exposure to excess weight and assess strength of association with CRC risk. Utilizing DACHS, a population-based case-control study of CRC that has been ongoing in the Rhine Neckar region of Southwest Germany since 2003, they selected patients aged ≥30 years with a first diagnosis of CRC. For the control group, individuals were selected from population registries, matched by age, gender and county of residence. Participants were asked to provide information on height and weight at diagnosis or, in the case of controls, at the time of recruitment. For the study, body mass index (BMI) was calculated for each year of age from age 20 to the current age. Then excess BMI for each year was determined as BMI minus 25 (the borderline between normal BMI and overweight) and summed across the ages to obtain weighted number of years lived with overweight/ obesity.

The analysis focused on 5,635 patients with CRC (mean age 68.4 years) and 4,515 controls (mean age 68.5 years).

  • Results showed the weighted number of years lived with overweight or obesity (WYOs) increased the odds ratio (OR) for CRC compared with participants who remained in the normal weight range. The WYOs were divided into quartiles, with OR 1.25 (1.09-1.44) for those in the lowest quartile; 1.41 (1.23-1.61) for those in the second quartile; 1.60 (1.40-1.83) for those in the third quartile; and 2.54 (2.24-2.89) for those in the highest quartile.
  • Each standard deviation (SD) increment in WYOs was associated with an increase of CRC risk of 55% (adjusted OR, 1.55; 95% CI. 1.46-1.64).

“Our proposed concept of WYOs is comparable to the concept of pack-years in that WYOs can be considered a weighted measure of years lived with the exposure, with weights reflecting the intensity of exposure,” write the authors.

Although the current study focused on CRC, they add, the same is likely to apply for other cancers and chronic diseases, making prevention of overweight and obesity to reduce the burden of cancer a public health priority.

In an accompanying editorial Patrick Bradshaw, from the University of California, Berkeley, writes that cumulative measures, such as pack-years and WYOs, are relevant when exposure is cumulative and unalterable. “But it is not clear to what extent this applies to excess adiposity. It is well understood that even modest intentional weight loss can reverse the deleterious metabolic profile thought to mediate obesity’s influence on chronic disease risk. Thus, an individual experiencing intentional weight loss, even attaining a BMI in the overweight or obese range, could be at much lower risk of disease compared with an individual with the same BMI who was not experiencing weight loss.”

Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Related Topics
  • Colorectal cancer
  • cumulative life-time exposure
  • obesity
  • overweight
Janet Fricker

Janet Fricker is a medical writer specialising in oncology and cardiology. After researching articles for Cancerworld she runs, swims, and eats porridge.

Previous Article
  • Articles
  • Policy

Do patents encourage or discourage innovation? Intellectual property from ancient Greece to the Covid pandemic

  • 18 March 2022
  • Adriana Albini
View Post
Next Article
  • News

Radiologists urged to report breast arterial calcification for CVD prevention

  • 30 March 2022
  • Janet Fricker
View Post
You May Also Like
View Post
  • News

Study highlights need to reanalyse genomics and genetics of metastatic tumours

  • Janet Fricker
  • 27 January 2023
View Post
  • News

Current cervical cancer screening paradigm fails older women

  • Janet Fricker
  • 26 January 2023
View Post
  • News

Call-to-arms for Europe to provide essential paediatric anti-cancer medicines

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Exercise-stimulated myokine production can extend survival in advanced prostate cancer

  • Janet Fricker
  • 9 January 2023
View Post
  • News

Five San Antonio take-aways to improve care of breast cancer patients

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Repurposed drug combination reduces risk of recurrence following surgery for colorectal cancer

  • Janet Fricker
  • 16 December 2022
View Post
  • News

Aerobic activity to outcompete metastasis 

  • Janet Fricker
  • 2 December 2022
View Post
  • News

Ending cancer inequalities: European summit showcases new tools to inform policy

  • Anna Wagstaff
  • 30 November 2022

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

search
or search in Cancerworld archive
Newsletter

Subscribe free to
Cancerworld!

We'll keep you informed of the latest features and news with a fortnightly email

Subscribe now
Latest News
  • Study highlights need to reanalyse genomics and genetics of metastatic tumours
    • 27 January 2023
  • Current cervical cancer screening paradigm fails older women
    • 26 January 2023
  • Call-to-arms for Europe to provide essential paediatric anti-cancer medicines
    • 9 January 2023
  • Exercise-stimulated myokine production can extend survival in advanced prostate cancer
    • 9 January 2023
  • Five San Antonio take-aways to improve care of breast cancer patients
    • 16 December 2022
Article
  • The cancer patients still struggling to access drugs in the wake of anti-corruption reforms
    • 27 January 2023
  • Immunotherapy: outcomes of ultra low-dose trial offer hope for better global access
    • 26 January 2023
  • Cervical cancer elimination efforts boosted by simpler ways to identify and treat pre-cancerous lesions
    • 12 January 2023
Latest printed issue
Social

Would you follow us ?

Contents
  • AI in Genomics and Reporting for Clinical Practice
    • 26 January 2023
  • Telemedicine in Cancer Care: Monitoring, Follow-Up,Tele-Rehabilitation, Palliative and Supportive Care
    • 23 January 2023
  • AI application in diagnosis
    • 11 January 2023
MENU
  • About the Magazine
    • Editorial Team
    • Leadership and Management
    • Events
    • Magazine
    • Archive
    • Contacts
  • Articles
    • Policy
    • Practice Points
    • Delivery of Care
    • Biology basic
    • Medicine
    • Featured
  • Contents
    • News
    • Editorials
    • Interviews to the Expert
    • In the Hot Seat
    • Profiles
    • Obituaries
    • Voices
    • Partnership
    • Supported contents
  • Media Corner
    • Journalist Cancer Guide
    • Cancer Journalism Award
    • Cancer Journalist Grant
Cancerworld Magazine
  • About the Magazine
  • Articles
  • Media Corner
  • Privacy Policy
  • Cookie Policy

Cancerworld is funded by SPCC Sharing Progress in Cancer Care | Via Vincenzo Vela 6, 6500 Bellinzona - Switzerland | info@spcc.net

Archivio Cancerworld

Input your search keywords and press Enter.